Semaglutide weight loss outcomes in STEP-1 trial
study031
10.1056/NEJMoa2032183
New England Journal of Medicine
randomized clinical trial
Semaglutide was studied for obesity treatment in non-diabetic adults.
Participants achieved substantial weight loss relative to placebo.
semaglutide
fat-loss|metabolism
metabolic-stack
semaglutide-vs-tirzepatide
published